vesnarinone has been researched along with Chronic Disease in 5 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vesnarinone (VES) has been used for treatment of patients with congestive heart failure." | 1.29 | Effects of vesnarinone, a novel orally active inotropic agent with an immunosuppressive action, on experimental cardiac transplantation in rats. ( DiSesa, VJ; Fyfe, BS; Goldstein, C; Mohiuddin, M; Momeni, R; Shen, Z; Whitman, GJ; Yokoyama, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanoi, H | 1 |
| Inoue, H | 1 |
| Toyama, J | 1 |
| Kamiya, K | 1 |
| Cheng, J | 1 |
| Lee, JK | 1 |
| Suzuki, R | 1 |
| Kodama, I | 1 |
| Yokoyama, H | 1 |
| Momeni, R | 1 |
| Goldstein, C | 1 |
| Mohiuddin, M | 1 |
| Shen, Z | 1 |
| Fyfe, BS | 1 |
| Whitman, GJ | 1 |
| DiSesa, VJ | 1 |
| Soran, O | 1 |
| Young, JD | 1 |
| Holubkov, R | 1 |
| Loftus, S | 1 |
| Bourge, R | 1 |
| Carson, P | 1 |
| Jaski, B | 1 |
| White, BG | 1 |
| Feldman, AM | 1 |
1 review available for vesnarinone and Chronic Disease
| Article | Year |
|---|---|
Ion channel blockers in the treatment of chronic heart failure.
Topics: Amiodarone; Animals; Calcium Channel Blockers; Chronic Disease; Heart Failure; Humans; Potassium Cha | 1996 |
2 trials available for vesnarinone and Chronic Disease
| Article | Year |
|---|---|
Effect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: results of the vesnarinone trial withdrawal substudy. Vest Withdrawal Substudy Group.
Topics: Cardiotonic Agents; Cause of Death; Chronic Disease; Disease Progression; Follow-Up Studies; Heart F | 1999 |
A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure. OPC-8212 Multicenter Research Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiotonic Agents; Chronic Disease; Dou | 1990 |
2 other studies available for vesnarinone and Chronic Disease
| Article | Year |
|---|---|
Positive inotropic agents: a double-edged sword for chronic heart failure.
Topics: Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Hea | 1996 |
Effects of vesnarinone, a novel orally active inotropic agent with an immunosuppressive action, on experimental cardiac transplantation in rats.
Topics: Acute Disease; Animals; Cardiotonic Agents; Chronic Disease; Graft Rejection; Heart Transplantation; | 1996 |